查詢結果分析
來源資料
相關文獻
- 晚期膀胱癌: 手術前放射治療與手術後放射治療之比較
- Preoperative Radiotherapy and Chemotherapy for Low or Locally Advanced Rectal Cancer
- 慢性鼻竇炎手術前後鼻腔黏液纖毛清除功能的比較
- Laparoscopic Low Anterior Resection for Selected Mid and Low Rectal Cancers
- 非早期食道癌:單獨放射治療及手術前放射治療之結果
- Preoperative Weekly 24-hour Infusion of High-dose 5-Fluorouracil and Leucovorin (HDFL) with Concurrent Radiation for T3, T4 Rectal Cancer on a Outpatient Basis
- Preliminary Results of Preoperative Chemoradiation Therapy for Cervical Esophageal Squamous Cell Carcinoma with Larynx Preservation
- Prolonging the Interval between Neoadjuvant Concurrent Chemoradiotherapy and Surgery Improves Pathological Outcomes in Rectal Cancer
- Preoperative Chemoradiotherapy Followed by Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Single Center Experience in Southern Taiwan
- The Clinical Outcome of Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
頁籤選單縮合
題 名 | 晚期膀胱癌: 手術前放射治療與手術後放射治療之比較 |
---|---|
作 者 | 張國華; | 書刊名 | 醫學研究 |
卷 期 | 9:3 1988.11[民77.11] |
頁 次 | 頁203-208 |
分類號 | 416.274 |
關鍵詞 | 手術; 比較; 放射治療; 前; 晚期; 膀胱癌; |
語 文 | 中文(Chinese) |
中文摘要 | 本院放射腫瘤科與泌尿外科合作,自1981年1月至1984年6月間,共有50位較晚期的膀胱癌患者接受放射線及手術合併治療。其中27位是接受手術前放射治療,其治療方式為,病人先接受全骨盆放射線治療,每週治療5天,每天一次照射400厘葛雷(CGY),總共治療2000厘葛雷,之後立刻安排膀胱切除手術,若手術後發現骨盆淋巴轉移者,再加強放射治療,治療劑量亦為2000厘葛雷/5次/1週。另外23位病人是先按膀胱切除手術,因發現腫瘤浸潤較深,或發現骨盆淋巴轉移等問題,再加上手術後之放射治療,治療之方法為全骨盆照射5040厘葛雷/28次/5½週。治療之結果發現手術前放射治療患者之5年存活率比手術後放射治療病患者高,分別為61%及41%,(P<0.05)。而手術前放射治療及手術後放射治療患者之遠端轉移率分列為26%及39%,復發率分別為7%及13%,併發症發生率分別為3.7%及8.6%,皆為手術前放射治療患者較低,但因人數太少,在統計學上並無明顯之差異,須做更進一步之研究。 |
英文摘要 | From January 1981 to December 1984, a total of 50 patients with urinary bladder carcinoma were treated with combination of radiotherapy and surgery. Out of the 50 patients, 27 patients were treated with postoperative radiotherapy and 23 patients received preoperative radiotherapy. The preoperative radiotherapy technique was giving a total dose of 2,000 cGy over 5 days to the whole pelvis through the anterior and posterior portals using Cobalt-60 while in the postoperative radiotherapy group, a total dose of 5,000 cGy over 5 weeks was given to the whole pelvis. The actuarial 5 year survival rate for the preoperative group and the postoperative group was 61% vs. 41% respectievely, The incidence of distant metastasis is 26% vs. 39%. Recurrence rates of 7% vs. 13%, overall complication rates of 3.7% vs. 8.6%. These indicate a better result for the preoperative group. |
本系統中英文摘要資訊取自各篇刊載內容。